Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Dysgeusia, Headache, Nasal congestion
Clinical narrative: started to notice things smelling differently. Mold was more pungent, perfumes a bit more musky, onions like they were a bit older; My taste is now very metal like and sour; Food now taste different; My mucus in my nose is much much thicker now and my mouth saliva produces lots more than it did; My mouth saliva produces lots more than it did; Headache; pain at injection site; fever in injection arm only; joint pain in injection arm; some diarrhea; some aches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date May2021 (Lot number: EW0161) at the age of 49 years as dose 2, single and administered in arm left, administration date 26Apr2021 08:00 (Lot number: ER2613) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergy-Penicillin" (unspecified if ongoing); "Known allergy-Peanuts" (unspecified if ongoing); "Covid-19", start date: Jan2021 (unspecified if ongoing), notes: After having Covid for 10 days in January. Concomitant medication(s) included: ZINC; VITAMIIN C; VITAMIN D3. The following information was reported: HEADACHE (non-serious) with onset 2021, outcome "not recovered", described as "Headache"; VACCINATION SITE PAIN (non-serious) with onset 2021, outcome "not recovered", described as "pain at injection site"; PYREXIA (non-serious) with onset 2021, outcome "not recovered", described as "fever in injection arm only"; ARTHRALGIA (non-serious) with onset 2021, outcome "not recovered", described as "joint pain in injection arm"; DIARRHOEA (non-serious) with onset 2021, outcome "not recovered", described as "some diarrhea"; PAIN (non-serious) with onset 2021, outcome "not recovered", described as "some aches"; PAROSMIA (non-serious) with onset 01Jun2021 20:00, outcome "not recovered", described as "started to notice things smelling differently. Mold was more pungent, perfumes a bit more musky, onions like they were a bit older"; DYSGEUSIA (non-serious) with onset 01Jun2021 20:00, outcome "not recovered", described as "My taste is now very metal like and sour"; TASTE DISORDER (non-serious) with onset 01Jun2021 20:00, outcome "not recovered", described as "Food now taste different"; NASAL CONGESTION (non-serious) with onset 01Jun2021 20:00, outcome "not recovered", described as "My mucus in my nose is much much thicker now and my mouth saliva produces lots more than it did"; SALIVARY HYPERSECRETION (non-serious) with onset 01Jun2021 20:00, outcome "not recovered", described as "My mouth saliva produces lots more than it did". The events "headache", "pain at injection site", "fever in injection arm only", "joint pain in injection arm", "some diarrhea", "some aches", "started to notice things smelling differently. mold was more pungent, perfumes a bit more musky, onions like they were a bit older", "my taste is now very metal like and sour", "food now taste different", "my mucus in my nose is much much thicker now and my mouth saliva produces lots more than it did" and "my mouth saliva produces lots more than it did" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of headache, vaccination site pain, pyrexia, arthralgia, diarrhoea, pain, parosmia, dysgeusia, taste disorder, nasal congestion, salivary hypersecretion.  Additional information: Facility where the most recent COVID-19 vaccine was administered was workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.